InGeNA stakeholders consulted

InGeNA stakeholders consulted

InGeNA’s appointed consultant Voronoi led by Gil Carter has completed stakeholder engagement workshops as part of the Data and Technology Innovation project Industry’s role in driving value from genomics information management in Australia. They invited InGeNA...
Integrating genomics into care: Highlights from HealthData21

Integrating genomics into care: Highlights from HealthData21

Presentations from the InGeNA conference, HealthData21, are available to delegates on the virtual platform. AIDH Members will have access to it from September on Digital Health TV, the Institute’s own exclusive digital health channel for Fellows and Members. The Hon...
Message from the Chair

Message from the Chair

A collaborative approach is critical to the work of InGeNA. We work on the principle that to make progress efficiently we need to reduce duplication of effort and make a meaningful contribution.  We want to be inclusive in everything we do.InGeNA has recently joined...
Industry role in driving value from genomics information management

Industry role in driving value from genomics information management

Data governance, particularly sovereignty and patient data ownership models will be examined in a new report commissioned by InGeNA.  The report will explore industry’s role in driving value from genomics information management in Australia.It will consider how...
Webinar: Rethinking the ethical and effective use of genomic data

Webinar: Rethinking the ethical and effective use of genomic data

Join this webinar to hear from two non-industry perspectives – patient advocacy and research – on how data sharing can be best harnessed for clinical and research use. Jan Mumford joined the InGeNA working group to provide the patient perspective. She will talk...
InGeNA launches strategic plan

InGeNA launches strategic plan

Quantifying the benefits of genomics is a key focus of the InGeNA Strategic Plan launched today. InGeNA has commenced a major project with Deloitte Access Economics to develop an evidence base to demonstrate the value of genomics to the economy, society and patient...